Table 2 Comparison between SAGIT components of three study groups.

From: The potential utility of the SAGIT instrument in the clinical assessment of patients with acromegaly, a large single-centre study

 

Naïve

N = 55

Non-remission group

N = 145 patient-admissions

Stable/controlled group

N = 116 patient-admissions

p

S

1 (0–2)*#

0 (0–1)*

0 (0–1)#

0.003176

A

2 (1–2)*

2 (1–3)*#

2 (1–3)#

0.01

G

4 (2–4)*

2 (1.75–3)*

0 (0–1)*

 < 0.000001

I

3 (2–3)*

1 (0–3)*

0 (0–0)*

 < 0.000001

T

2 (1–4)*

2 (0–4)*

0 (0–1)*

 < 0.000001

  1. Note: Data marked with the same markers differ significantly.